Ad hoc Announcements
Listed companies are obliged by law to publish without delay news of all company occurences that could influence the share price significantly (section 15 of the German Securities Trading Act).
| Date | Title | Download |
| 07/27/2011 | Merck KGaA: Q2/2011: One-time adjustments lead to lower guidance on Group operating result for 2011 to approximately € 1 billion |  (10 kb) |
| Date | Title | Download |
| 12/13/2010 | Merck KGaA: Changes in the Executive Board | (7 kb) |
| 09/24/2010 | Merck KGaA: Negative CHMP Opinion for Cladribine Tablets in Multiple Sclerosis | |
| 07/29/2010 | Merck KGaA: Q2/2010: Profit After Tax Jumps 70% to EUR 187 Million – Merck Raises Group Outlook 2010 | (97 kb) |
| 07/28/2010 | Merck KGaA: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis | (9 kb) |
| 02/28/2010 | Merck KGaA to Acquire Millipore – Creating a World-Class Partner for the Life Science Sector | (15 kb) |
No ad-hoc announcements were published in 2008.
| Date | Title | Download |
| 09/11/2007 | Merck: Erbitux Phase III Study – FLEX Increases Overall Survival in
First-line Treatment of Non-Small Cell Lung Cancer | (7 kb) |
| 05/13/2007 | Merck KGaA: Merck Sells Generics Business to Mylan for EUR 4.9 Billion | (12 kb) |
| 02/21/2007 | Merck KGaA: Karl-Ludwig Kley to Succeed Michael Roemer as Chairman of the Executive Board | (11 kb) |
| Date | Title | Download |
| 09/21/2006 | Merck KGaA acquires majority stake in Serono SA | Link |
| 06/23/2006 | Merck KGaA: Development of Sarizotan to treat Parkinson’s patients will not be pursued | (10 kb) |
| 06/14/2006 | Merck KGaA: Merck To Transfer Its Schering Shares to Bayer | (69 kb) |
| 03/24/2006 | Merck KGaA Will Not Increase Its Offer for Schering AG | (15 kb) |
| 03/13/2006 | Merck KGaA Announces Takeover Offer for Schering AG | (70 kb) |
| 03/13/2006 | Announcement pursuant to Section 10 of the German Securities Acquisition and Takeover Act | (37 kb) |
| 11/22/2005 | Merck KGaA Announces New Leadership | (40 kb) |
| 09/29/2005 | Merck KGaA and Takeda to Co-Develop and Co-Promote Matuzumab Cancer Treatment | (12 kb) |
| 02/08/2005 | Merck KGaA Acquires Avecia’s OLED and Polymer Electronics Units | (12 kb) |
_tcm1612_71054.jpg "Annual Report 2010"){kind=small}
